Japonica Rice: Intellectual Property, Scientific Publishing and Data‐sharing1

  title={Japonica Rice: Intellectual Property, Scientific Publishing and Data‐sharing1},
  author={Matthew Rimmer},
  pages={325 - 347}
  • M. Rimmer
  • Published 1 July 2005
  • Economics
  • Prometheus
Abstract This article examines a series of controversies within the life sciences over data sharing. Part 1 focuses upon the agricultural biotechnology firm Syngenta publishing data on the rice genome in the journal Science, and considers proposals to reform scientific publishing and funding to encourage data sharing. Part 2 examines the relationship between intellectual property rights and scientific publishing, in particular copyright protection of databases, and evaluates the declaration of… 
6 Citations

A Comparison of the Legal Protection of Databases in the United States and EU: Implications for Scientific Research

In this paper the laws governing the protection of databases in Europe and the United States are considered, as they provide a useful comparison of different approaches to protection. The potential

A Submission to the Senate Community Affairs Committee Inquiry into Gene Patents

Inquiry into Gene Patents Submissions Received by the Committee during the 42nd Parliament

Inquiry into Gene Patents



Beyond Blue Gene: Intellectual Property and Bioinformatics

This article considers the challenges posed to intellectual property law by the emerging field of bioinformatics. It examines the intellectual property strategies of established biotechnology

Geneticists get steamed up over public access to rice genome

Twenty top genome researchers have written to the editorial advisers of Science protesting at the way the journal occasionally publishes genome maps without requiring the authors to place the supporting sequence data in public databases, arguing that new genome sequences should be made available in public-domain databases.

The race to patent the SARS virus: The TRIPS agreement and access to essential medicines

There is a need to reform the patent system to accommodate the global nature of scientific inquiry, the unique nature of genetics, and the pace of technological change to accommodate international research efforts on infectious diseases.

International conflicts over patenting human DNA sequences in the United States and the European Union: an argument for compulsory licensing and a fair-use exemption.

Professor Gitter proposes a dual reform: a compulsory licensing regime requiring holders of DNA sequence patents to license them to commercial researchers, in return for a royalty keyed to the financial success of the product that the licensee develops; and an experimental-use exemption from this regime for government and nonprofit researchers.

Making Dollars out of DNA: The First Major Patent in Biotechnology and the Commercialization of Molecular Biology, 1974-1980

This essay describes how the patenting procedure was shaped by the concurrent recombinant DNA controversy, tension over the commercialization of academic biology, governmental deliberations over the regulation of genetic engineering research, and national expectations for high technology as a boost to the American economy.

A Deal for the Rice Genome

THE RICE GENOMEFor the second time in just over a year, Science is at the center of a debate over public access to the data behind a major genome paper it is publishing. The issue: Should journals

Clear-Cut Publication Rules Prove Elusive

A select group of scientists and journal editors met last week to chisel out some commandments for their peers on the ethics of publishing, but the participants clashed on what it means to make the data backing a published claim "freely available".

A universal legal framework as a prerequisite for database interoperability

The US Congress is currently attempting to augment weak copyright protections in database protection, and in doing so, US lawmakers need to consider the repercussions of their legislation on scientific research.

Data withholding in academic genetics: evidence from a national survey.

Data withholding occurs in academic genetics and it affects essential scientific activities such as the ability to confirm published results.